CHFR and nasopharyngeal carcinoma: In the study of Cheung and colleagues, hypermethylation of CHFR promoter CpG was detected in 100% NPC cell lines and xenografts (11 out of 11) and in 61.1% (22 out of 36) of NPC samples, but not in nonmalignant nasopharyngeal cell lines or tissues.